Greenwood Capital Associates LLC Sells 368 Shares of Cutera, Inc. (NASDAQ:CUTR)

Greenwood Capital Associates LLC decreased its holdings in Cutera, Inc. (NASDAQ:CUTR) by 1.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,319 shares of the medical device company’s stock after selling 368 shares during the period. Greenwood Capital Associates LLC owned about 0.21% of Cutera worth $609,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Parametric Portfolio Associates LLC grew its stake in shares of Cutera by 22.8% in the second quarter. Parametric Portfolio Associates LLC now owns 30,758 shares of the medical device company’s stock worth $639,000 after acquiring an additional 5,716 shares during the period. Bogle Investment Management L P DE lifted its stake in shares of Cutera by 1.4% in the 2nd quarter. Bogle Investment Management L P DE now owns 84,718 shares of the medical device company’s stock worth $1,760,000 after purchasing an additional 1,200 shares during the period. Northern Trust Corp lifted its stake in shares of Cutera by 0.4% in the 2nd quarter. Northern Trust Corp now owns 218,955 shares of the medical device company’s stock worth $4,549,000 after purchasing an additional 802 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Cutera by 7.4% in the second quarter. Renaissance Technologies LLC now owns 648,600 shares of the medical device company’s stock worth $13,478,000 after buying an additional 44,600 shares during the last quarter. Finally, Quantamental Technologies LLC purchased a new position in shares of Cutera in the second quarter worth approximately $37,000. Hedge funds and other institutional investors own 90.67% of the company’s stock.

NASDAQ CUTR traded up $0.01 during trading hours on Wednesday, reaching $30.02. The company’s stock had a trading volume of 202 shares, compared to its average volume of 126,037. Cutera, Inc. has a 1 year low of $12.32 and a 1 year high of $35.85. The company has a quick ratio of 1.16, a current ratio of 1.67 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $409.74 million, a price-to-earnings ratio of -13.42 and a beta of 0.87. The firm’s 50-day moving average price is $28.68 and its 200-day moving average price is $21.04.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Thursday, August 8th. The medical device company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.20. The business had revenue of $47.77 million during the quarter, compared to analyst estimates of $42.08 million. Cutera had a negative net margin of 20.49% and a negative return on equity of 69.92%. The company’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the firm posted $0.12 EPS. Equities research analysts anticipate that Cutera, Inc. will post -0.55 EPS for the current fiscal year.

A number of brokerages have commented on CUTR. ValuEngine cut shares of Cutera from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. Maxim Group reiterated a “hold” rating on shares of Cutera in a research note on Friday, August 9th. Zacks Investment Research raised shares of Cutera from a “hold” rating to a “strong-buy” rating and set a $38.00 target price for the company in a report on Wednesday, August 14th. Sidoti cut shares of Cutera from a “buy” rating to a “neutral” rating in a research note on Thursday, August 22nd. Finally, BidaskClub raised shares of Cutera from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 13th. Four equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $35.50.

Cutera Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Recommended Story: What is an Initial Coin Offering (ICO)?

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.